Hangzhou ConVerd Co., Ltd.
PrivateLast Round
Strategic
Sep 15, 2017
Total Funding Raised
$4.6M
Company Overview
Hangzhou ConVerd Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Strategic round in September 2017.
Hangzhou ConVerd Co., Ltd. is a biotechnology company focused on the research and development of oncolytic viruses and other cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou ConVerd Co., Ltd. Comparables
Compare Hangzhou ConVerd Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuhan Binhui Biopharmaceutical Co., Ltd. | 88% | |
| Virogin Biotech | 84% | |
| ImmVira | 83% |
For institutional investors. Book with your work email.
Hangzhou ConVerd Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Hangzhou ConVerd Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Resources | Strategic |
| Morningside Group | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 399% MoM.
- Nov 9, 2025
Monthly visitors increased 87% MoM.
For institutional investors. Book with your work email.
Hangzhou ConVerd Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou ConVerd Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou ConVerd Co., Ltd. a public or private company?
Hangzhou ConVerd Co., Ltd. is a private company.
What is the current stock price of Hangzhou ConVerd Co., Ltd.?
Hangzhou ConVerd Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou ConVerd Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou ConVerd Co., Ltd. worth (valuation)?
Valuation information for Hangzhou ConVerd Co., Ltd. is not publicly available.
Can I buy Hangzhou ConVerd Co., Ltd. stock?
Hangzhou ConVerd Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou ConVerd Co., Ltd.'s last funding round?
Hangzhou ConVerd Co., Ltd.'s most recent funding round was Strategic on September 15, 2017.
Who are the main investors in Hangzhou ConVerd Co., Ltd.?
Key investors in Hangzhou ConVerd Co., Ltd. include China Resources, Morningside Group.
Will Hangzhou ConVerd Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou ConVerd Co., Ltd..
How can I track Hangzhou ConVerd Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou ConVerd Co., Ltd.'s shares on secondary markets.